|1.||Löppenberg, Marius: 1 article (02/2014)|
|2.||Holl, Ralph: 1 article (02/2014)|
|3.||Sippl, Wolfgang: 1 article (02/2014)|
|4.||Jose, Joachim: 1 article (02/2014)|
|5.||Melesina, Jelena: 1 article (02/2014)|
|6.||Szermerski, Marina: 1 article (02/2014)|
|7.||Wichapong, Kanin: 1 article (02/2014)|
04/23/1996 - "Expression of the mouse mastocytoma glucosaminyl N-deacetylase/ N-sulfotransferase in human kidney 293 cells results in increased N-sulfation of heparan sulfate."
04/08/1994 - "A 110-kDa protein involved in heparin biosynthesis in mouse mastocytoma cells was previously shown to express both glucosaminyl N-deacetylase and N-sulfotransferase activity. "
04/08/1994 - "cDNA cloning and sequencing of mouse mastocytoma glucosaminyl N-deacetylase/N-sulfotransferase, an enzyme involved in the biosynthesis of heparin."
|2.||Diabetic Nephropathies (Diabetic Nephropathy)
06/01/1993 - "Impaired heparan sulphate biosynthesis through diabetes-induced inhibition of glucosaminyl N-deacetylase may have a central role in the development of diabetic nephropathy, and genetic differences in the vulnerability of the N-deacetylase could influence the risk of developing nephropathy. "
06/01/1993 - "Glucosaminyl N-deacetylase in cultured fibroblasts; comparison of patients with and without diabetic nephropathy, and identification of a possible mechanism for diabetes-induced N-deacetylase inhibition."
04/01/1992 - "It is concluded that the diabetes induced inhibition of glucosaminyl N-deacetylase may play an important role in the pathogenesis of diabetic nephropathy."
|4.||Diabetic Angiopathies (Diabetic Angiopathy)
|1.||Complementary DNA (cDNA)
|2.||Uridine Diphosphate (UDP)
|3.||Heparitin Sulfate (Heparan Sulfate)
|5.||Blood Glucose (Blood Sugar)